1. Reassessing the Role of Somatostatin Analogs in the Treatment of NETs

2. Activity Goals

3. Categories of NETs

4. Carcinoid Tumors

5. Symptoms From Hormone Production

6. Somatostatin Analog

7. The PROMID Study Design

8. PROMID Study Results

9. CLARINET Study

10. CLARINET Study: Results

11. Differences Between Studies

12. Phase 3: Pasireotide vs Octreotide

13. Phase 3 Study: Results

14. Curve to Show Difference in Disease Control?

15. ELECT Study

16. ELECT Study

17. Temozolomide-based Regimens

18. CAPTEM

19. PFS and OS With CAPTEM

20. Conclusions

21. Streptozocin-based Regimens

22. Abbreviations

23. Abbreviations (cont)

24. References

25. References (cont)

26. References (cont)

27. References (cont)

28. References (cont)

29. References (cont)

30. References (cont)